A fixed-dose combination of a lipotropic agent (Tricholine Citrate) and an osmotic laxative/sweetener (Sorbitol). Primarily used as a hepatoprotective and choleretic agent to support liver function and promote bile flow, while Sorbitol aids in gentle bowel evacuation and serves as a sweetening vehicle. It is a cornerstone in the management of various hepatic disorders and dyspeptic symptoms in the Indian clinical setting.
Adult: 15 ml (approximately one tablespoon) two to three times daily, or as directed by the physician. Usually taken after meals.
Note: Shake the bottle well before use. Use the measuring cup or spoon provided. Dilution in a half glass of water is optional but can improve palatability. Administer after meals to reduce GI upset and align with digestive processes.
Tricholine Citrate acts as a lipotropic agent by providing choline, which is essential for the synthesis of phosphatidylcholine, a key component of cell membranes and very-low-density lipoproteins (VLDL). This promotes hepatic export of triglycerides, preventing fatty infiltration. It also has choleretic action, stimulating bile production and flow. Sorbitol, a hexahydric alcohol, exerts an osmotic effect in the gastrointestinal lumen, drawing water into the colon to soften stools and stimulate peristalsis, relieving constipation often associated with liver dysfunction.
Pregnancy: Category B: Animal reproduction studies have not shown a risk, but no adequate, well-controlled studies in pregnant women. Use only if potential benefit justifies potential risk to the fetus.
Driving: No known effects. However, if dizziness occurs as a side effect, caution is advised.
| Oral Hypoglycemic Agents (e.g., Metformin) | Sorbitol may cause diarrhea, affecting blood sugar control. Tricholine may have mild hypoglycemic effect. | Moderate |
| Diuretics (e.g., Furosemide) | Additive risk of electrolyte imbalance (hypokalemia) with Sorbitol-induced diarrhea. | Moderate |
| Digoxin | Hypokalemia from Sorbitol can potentiate digoxin toxicity. | Major |
| Other Laxatives or Lactulose | Additive laxative effect, increasing risk of severe diarrhea and dehydration. | Major |
| Anticoagulants (e.g., Warfarin) | Theoretical interaction due to potential vitamin K metabolism changes; monitor INR. | Moderate |